Switzerland · Who invested in Allegria Therapeutics?
Allegria Therapeutics's investors include Highlight Capital.
Switzerland · Funded startup
Who invested in Allegria Therapeutics
Funding summaryUpdated 26 Oct 2026
$1.5Mraised across 1 round since 2026, from 1 source
- Latest round
- Grant, $1.5MApr 2026
- Investors
- 1
The rounds
- Apr 2026
Founders and team
From Allegria Therapeutics's own website: 1 founder, 5 on the team.
Maria van DongenCEO & Co-founder, Director
- Patrick SieberVP Operations
- Johanna KammannScientific Writer & Project Manager
- Peter Sejer AndersenBoard Member
- Sara Núñez-GarcíaChairperson
- Sascha Oliver BucherBoard Member
AdvisersDavid EvansIntellectual PropertyPhilipp StarklTamás Schweighoffer
Quick answers about Allegria Therapeutics
How much has Allegria Therapeutics raised?
Allegria Therapeutics has raised $1.5M across 1 round since 2026.
When did Allegria Therapeutics last raise?
Allegria Therapeutics's most recent round was a Grant of $1.5M in Apr 2026.
What was Allegria Therapeutics's biggest round?
Its most recent round, $1.5M in Apr 2026, is also its largest on record.
Who backed Allegria Therapeutics first?
Allegria Therapeutics's first round on record, in Apr 2026, was backed by Highlight Capital.
What stage is Allegria Therapeutics at?
Allegria Therapeutics's latest named round is a Grant, in Apr 2026.
Where is Allegria Therapeutics based?
Allegria Therapeutics is based in Switzerland.
Companies like Allegria Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.